$QNTA “We have been looking forward to sharing these positive results with the world and see this as a steppingstone to solidifying Aelia’s position as a leader in topical pain relief products using CBD,” said Medolife CEO Dr. Arthur Mikaelian. “We have faith that in the future our proprietary polarization technology can become a standard in high-quality product formulations as we continue to expand on the science and capabilities of polarization.”